Researchers urge stronger warning for indoor tanning risks

April 08, 2015

AURORA, Colo. (April 8, 2015) - The U.S. Surgeon General should declare that indoor ultraviolet radiation tanning causes skin cancer, according to an article published today by the American Journal of Preventive Medicine.

Robert P. Dellavalle, MD, PhD, MSPH, associate professor of dermatology at the University of Colorado School of Medicine on the Anschutz Medical Campus, is the corresponding author of the article, which says there is enough evidence for the Surgeon General to clearly state that use of indoor tanning beds causes skin cancer.

Dellavalle and his co-authors use a common testing standard for causality, named after English epidemiologist Sir Austin Bradford Hill, to compare the case made in 1964 by the Surgeon General to link cigarette smoking to lung cancer to today's concerns about indoor ultraviolet (UV) tanning and skin cancer.

"As with tobacco and lung cancer, all Bradford Hill criteria except the experimental criteria are satisfied by the relationship between indoor UV tanning and skin cancer: tanning beds cause skin cancer," the authors write. "It is time now to announce this causality more openly."

The Bradford Hill criteria provide nine categories for evaluating the causal relationship between two factors. The authors report that for indoor UV tanning and skin cancer and for smoking and lung cancer, each fulfill eight of the nine criteria.

The remaining item, conducting "randomized controlled trials" on human subjects, cannot be tested because it would be unethical to expose humans to activities known to cause cancer, the authors write. According to the International Agency for Research on Cancer, which is part of the World Health Organization, UV tanning devices and tobacco smoke are classified as Group 1 carcinogens.

Based on the comparison with tobacco smoke and the health warning issued by the Surgeon General, the authors urge the Surgeon General to make a stronger statement than has been made so far regarding UV tanning devices.
Dellavalle's co-authors are Chante Karimkhani, BA, Lindsay N. Boyers, BA, and Lisa M. Schilling, MD, MSPH.

About the University of Colorado School of Medicine

Faculty at the University of Colorado School of Medicine work to advance science and improve care. These faculty members include physicians, educators and scientists at University of Colorado Health, Children's Hospital Colorado, Denver Health, National Jewish Health, and the Denver Veterans Affairs Medical Center. The school is located on the Anschutz Medical Campus, one of four campuses in the University of Colorado system. To learn more about the medical school's care, education, research and community engagement, visit its web site.

Contact: Mark Couch, 303-724-5377,

University of Colorado Anschutz Medical Campus

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to